The Latest in Hematology Times

Survey suggests docs could improve trial enrollment

August 2, 2013

Related Issues

Fraud, errors were behind delay of apixaban approval, report shows

July 10, 2013

Fusion protein controls surgery-related bleeding in hemophilia B

July 7, 2013

Thrombosis

Canada alters blood donor policy for MSM

May 24, 2013

Blood Banking

New antiplatelet drug seems more effective than standard

March 13, 2013

Thrombosis

FDA again rejects rivaroxaban for ACS

March 6, 2013

Thrombosis

Dabigatran noninferior to warfarin for preventing recurrent VTE

February 22, 2013

Thrombosis

Company suspends enrollment in drug trials

February 21, 2013

FDA approves pomalidomide for MM

February 12, 2013

New antihemophilic factors last longer than standard treatments

February 11, 2013

Thrombosis

FDA approves plasma product

January 18, 2013

FDA approves apixaban for patients with NVAF

January 3, 2013

Thrombosis

Study supports extended apixaban use

December 14, 2012

Thrombosis

Findings could revolutionize malaria drug testing

November 15, 2012

Related Issues

Factor appears safe, effective in hemophilia B

September 27, 2012

Thrombosis